The Why and When of a Bisphosphonate Drug Holiday

Experts stress importance of understanding the benefit-to-risk balancing act of bone-building drugs.

0
The popular bone-building drugs called bisphosphonates are known for their powerful impact on regaining bone density and reducing fractures. Yet, recent headlines have questioned the long-term efficacy and safety of bisphosphonates in women who take them, causing many to wonder if the drugs benefits are worth the risk.Since the U.S. Food and Drug Administration (FDA) raised concerns in 2011 about the potential for serious side effects in women taking bisphosphonates, including alenodrate (Fosamax), risedronate (Actonel), zoledronic acid (Reclast) and ibandronate (Boniva), both physicians and their patients have been on alert.
To continue reading this article or issue you must be a paid subscriber. Sign in

Subscribe to Arthritis Advisor

Get the next year of Arthritis Advisor for just $20. And access all of our online content - over 1,000 articles - free of charge.
Subscribe today and save 36%. It's like getting 4 months FREE!
Already Subscribed?
Click Here to Sign In | Forgot your password? | Activate Web Access

LEAVE A REPLY

Please enter your comment!
Please enter your name here